FrancoV, FrenchJA, PeruccaE. Challenges in the clinical development of new antiepileptic drugs. Pharmacol Res, 2016; 103:94–104.
6.
LowensteinDH. Edging toward breakthroughs in epilepsy diagnostics and care. Nat Rev Neurol, 2015; 11:616–617.
7.
DravetC, BureauM, OguniH, FukuyamaY, CokarO. Severe myoclonic epilepsy in infancy: dravet syndrome. Adv Neurol, 2005; 95:71–102.
8.
DindayMR, BarabanSC. Large-scale phenotype-based antiepileptic drug screening in a zebrafish model of dravet syndrome (1,2,3). eNeuro, 2015:2; doi: 10.1523/ENEURO.0068-15.2015.
MortonCC, NanceWE. Newborn hearing screening: a silent revolution. N Engl J Med, 2006; 354:2151–2164.
11.
PandyaA, XiaX-J, ErdenetungalagR, AmendolaM, LandaB, RadnaabazarJ, DangaasurenB, Van TuyleG, NanceWE. Heterozygous point mutations in the mitochondrial tRNA Ser(UCN) precursor coexisting with the A1555G mutation in deaf students from Mongolia. Am J Hum Genet, 1999; 65:1803–1806.
12.
CoffinAB, WilliamsonKL, MamiyaA, RaibleD, RubelEW. Profiling drug-induced cell death pathways in the zebrafish lateral line. Apoptosis, 2013; 18:398–408.
13.
WhitfieldTT, GranatoM, van EedenFJ, SchachU, BrandM, Furutani-SeikiM, HaffterP, HammerschmidtM, HeisenbergCP, JiangYJ, KaneDA, KelshRN, MullinsMC, OdenthalJ, Nusslein-VolhardC. Mutations affecting development of the zebrafish inner ear and lateral line. Development, 1996; 123:241–254.
14.
KrugerM, BoneyR, OrdoobadiAJ, SommersT, TrapaniJG, CoffinAB. Natural bizbenzoquinoline derivatives protect zebrafish lateral line sensory hair cells from aminoglycoside toxicity. Front Cell Neurosci, 2016; 10:83.
15.
GuernseyDL, JiangH, CampagnaDR, EvansSC, FergusonM, et al.Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet, 2009; 41:651–653.
